Report cover image

Global Lidocaine Transdermal Patch Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 188 Pages
SKU # APRC20553202

Description

Summary

According to APO Research, The global Lidocaine Transdermal Patch market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Lidocaine Transdermal Patch is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Lidocaine Transdermal Patch is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Lidocaine Transdermal Patch is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Lidocaine Transdermal Patch is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Lidocaine Transdermal Patch include Teva Pharmaceutical, Tide Pharmaceutical (SINO BIOPHARM), Mylan, Teikoku, Sorrento Therapeutics, Par Pharmaceutical, Hisamitsu and Endo International, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Lidocaine Transdermal Patch, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Lidocaine Transdermal Patch, also provides the sales of main regions and countries. Of the upcoming market potential for Lidocaine Transdermal Patch, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Lidocaine Transdermal Patch sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Lidocaine Transdermal Patch market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Lidocaine Transdermal Patch sales, projected growth trends, production technology, application and end-user industry.

Lidocaine Transdermal Patch Segment by Company

Teva Pharmaceutical
Tide Pharmaceutical (SINO BIOPHARM)
Mylan
Teikoku
Sorrento Therapeutics
Par Pharmaceutical
Hisamitsu
Endo International
Lidocaine Transdermal Patch Segment by Type

Lidocare 1.80% Transdermal Patch
Lidocare 5% Transdermal Patch
Lidocare 4% Transdermal Patch
Lidocaine Transdermal Patch Segment by Application

Clinic
Hospital Pharmacies
Online Pharmacies
Chain Pharmacies
Monomer Pharmacies
Other
Lidocaine Transdermal Patch Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lidocaine Transdermal Patch market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Lidocaine Transdermal Patch and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lidocaine Transdermal Patch.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Lidocaine Transdermal Patch market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Lidocaine Transdermal Patch manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Lidocaine Transdermal Patch in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Lidocaine Transdermal Patch in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

188 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Lidocaine Transdermal Patch Market Size, 2020 VS 2024 VS 2031
1.3 Global Lidocaine Transdermal Patch Market Size Estimates and Forecasts (2020-2031)
1.4 Global Lidocaine Transdermal Patch Sales Estimates and Forecasts (2020-2031)
1.5 Global Lidocaine Transdermal Patch Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Lidocaine Transdermal Patch Market Dynamics
2.1 Lidocaine Transdermal Patch Industry Trends
2.2 Lidocaine Transdermal Patch Industry Drivers
2.3 Lidocaine Transdermal Patch Industry Opportunities and Challenges
2.4 Lidocaine Transdermal Patch Industry Restraints
3 Lidocaine Transdermal Patch Market by Manufacturers
3.1 Global Lidocaine Transdermal Patch Revenue by Manufacturers (2020-2025)
3.2 Global Lidocaine Transdermal Patch Sales by Manufacturers (2020-2025)
3.3 Global Lidocaine Transdermal Patch Average Sales Price by Manufacturers (2020-2025)
3.4 Global Lidocaine Transdermal Patch Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Lidocaine Transdermal Patch Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Lidocaine Transdermal Patch Manufacturers, Product Type & Application
3.7 Global Lidocaine Transdermal Patch Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Lidocaine Transdermal Patch Market CR5 and HHI
3.8.2 Global Top 5 and 10 Lidocaine Transdermal Patch Players Market Share by Revenue in 2024
3.8.3 2024 Lidocaine Transdermal Patch Tier 1, Tier 2, and Tier 3
4 Lidocaine Transdermal Patch Market by Type
4.1 Lidocaine Transdermal Patch Type Introduction
4.1.1 Lidocare 1.80% Transdermal Patch
4.1.2 Lidocare 5% Transdermal Patch
4.1.3 Lidocare 4% Transdermal Patch
4.2 Global Lidocaine Transdermal Patch Sales by Type
4.2.1 Global Lidocaine Transdermal Patch Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Lidocaine Transdermal Patch Sales by Type (2020-2031)
4.2.3 Global Lidocaine Transdermal Patch Sales Market Share by Type (2020-2031)
4.3 Global Lidocaine Transdermal Patch Revenue by Type
4.3.1 Global Lidocaine Transdermal Patch Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Lidocaine Transdermal Patch Revenue by Type (2020-2031)
4.3.3 Global Lidocaine Transdermal Patch Revenue Market Share by Type (2020-2031)
5 Lidocaine Transdermal Patch Market by Application
5.1 Lidocaine Transdermal Patch Application Introduction
5.1.1 Clinic
5.1.2 Hospital Pharmacies
5.1.3 Online Pharmacies
5.1.4 Chain Pharmacies
5.1.5 Monomer Pharmacies
5.1.6 Other
5.2 Global Lidocaine Transdermal Patch Sales by Application
5.2.1 Global Lidocaine Transdermal Patch Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Lidocaine Transdermal Patch Sales by Application (2020-2031)
5.2.3 Global Lidocaine Transdermal Patch Sales Market Share by Application (2020-2031)
5.3 Global Lidocaine Transdermal Patch Revenue by Application
5.3.1 Global Lidocaine Transdermal Patch Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Lidocaine Transdermal Patch Revenue by Application (2020-2031)
5.3.3 Global Lidocaine Transdermal Patch Revenue Market Share by Application (2020-2031)
6 Global Lidocaine Transdermal Patch Sales by Region
6.1 Global Lidocaine Transdermal Patch Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Lidocaine Transdermal Patch Sales by Region (2020-2031)
6.2.1 Global Lidocaine Transdermal Patch Sales by Region (2020-2025)
6.2.2 Global Lidocaine Transdermal Patch Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Lidocaine Transdermal Patch Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Lidocaine Transdermal Patch Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Lidocaine Transdermal Patch Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Lidocaine Transdermal Patch Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Lidocaine Transdermal Patch Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Lidocaine Transdermal Patch Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Lidocaine Transdermal Patch Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Lidocaine Transdermal Patch Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Lidocaine Transdermal Patch Revenue by Region
7.1 Global Lidocaine Transdermal Patch Revenue by Region
7.1.1 Global Lidocaine Transdermal Patch Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Lidocaine Transdermal Patch Revenue by Region (2020-2025)
7.1.3 Global Lidocaine Transdermal Patch Revenue by Region (2026-2031)
7.1.4 Global Lidocaine Transdermal Patch Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Lidocaine Transdermal Patch Revenue (2020-2031)
7.2.2 North America Lidocaine Transdermal Patch Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Lidocaine Transdermal Patch Revenue (2020-2031)
7.3.2 Europe Lidocaine Transdermal Patch Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Lidocaine Transdermal Patch Revenue (2020-2031)
7.4.2 Asia-Pacific Lidocaine Transdermal Patch Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Lidocaine Transdermal Patch Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Lidocaine Transdermal Patch Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Teva Pharmaceutical
8.1.1 Teva Pharmaceutical Comapny Information
8.1.2 Teva Pharmaceutical Business Overview
8.1.3 Teva Pharmaceutical Lidocaine Transdermal Patch Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Teva Pharmaceutical Lidocaine Transdermal Patch Product Portfolio
8.1.5 Teva Pharmaceutical Recent Developments
8.2 Tide Pharmaceutical (SINO BIOPHARM)
8.2.1 Tide Pharmaceutical (SINO BIOPHARM) Comapny Information
8.2.2 Tide Pharmaceutical (SINO BIOPHARM) Business Overview
8.2.3 Tide Pharmaceutical (SINO BIOPHARM) Lidocaine Transdermal Patch Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Tide Pharmaceutical (SINO BIOPHARM) Lidocaine Transdermal Patch Product Portfolio
8.2.5 Tide Pharmaceutical (SINO BIOPHARM) Recent Developments
8.3 Mylan
8.3.1 Mylan Comapny Information
8.3.2 Mylan Business Overview
8.3.3 Mylan Lidocaine Transdermal Patch Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Mylan Lidocaine Transdermal Patch Product Portfolio
8.3.5 Mylan Recent Developments
8.4 Teikoku
8.4.1 Teikoku Comapny Information
8.4.2 Teikoku Business Overview
8.4.3 Teikoku Lidocaine Transdermal Patch Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Teikoku Lidocaine Transdermal Patch Product Portfolio
8.4.5 Teikoku Recent Developments
8.5 Sorrento Therapeutics
8.5.1 Sorrento Therapeutics Comapny Information
8.5.2 Sorrento Therapeutics Business Overview
8.5.3 Sorrento Therapeutics Lidocaine Transdermal Patch Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Sorrento Therapeutics Lidocaine Transdermal Patch Product Portfolio
8.5.5 Sorrento Therapeutics Recent Developments
8.6 Par Pharmaceutical
8.6.1 Par Pharmaceutical Comapny Information
8.6.2 Par Pharmaceutical Business Overview
8.6.3 Par Pharmaceutical Lidocaine Transdermal Patch Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Par Pharmaceutical Lidocaine Transdermal Patch Product Portfolio
8.6.5 Par Pharmaceutical Recent Developments
8.7 Hisamitsu
8.7.1 Hisamitsu Comapny Information
8.7.2 Hisamitsu Business Overview
8.7.3 Hisamitsu Lidocaine Transdermal Patch Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Hisamitsu Lidocaine Transdermal Patch Product Portfolio
8.7.5 Hisamitsu Recent Developments
8.8 Endo International
8.8.1 Endo International Comapny Information
8.8.2 Endo International Business Overview
8.8.3 Endo International Lidocaine Transdermal Patch Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 Endo International Lidocaine Transdermal Patch Product Portfolio
8.8.5 Endo International Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Lidocaine Transdermal Patch Value Chain Analysis
9.1.1 Lidocaine Transdermal Patch Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Lidocaine Transdermal Patch Production Mode & Process
9.2 Lidocaine Transdermal Patch Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Lidocaine Transdermal Patch Distributors
9.2.3 Lidocaine Transdermal Patch Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.